SCHEMBL14837907

SCHEMBL14837907

CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OCC5(F)CCN(C(=O)O)CC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 19/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14837906 1.00 BCL2 (0.82) BCL2
SCHEMBL1701908 0.94 BCL2 (0.84) BCL2
SCHEMBL30314165 0.94 BCL2 (0.84) BCL2
SCHEMBL30314183 0.94 BCL2 (0.82) BCL2
SCHEMBL1700169 0.94 BCL2 (0.82) BCL2
SCHEMBL31344631 0.94 BCL2 (0.83) BCL2
SCHEMBL1699846 0.94 BCL2 (0.83) BCL2
SCHEMBL29629079 0.94 BCL2 (0.81) BCL2
SCHEMBL30313804 0.94 BCL2 (0.91) BCL2
SCHEMBL523310 0.94 BCL2 (0.91) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576546-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbvie Inc. (US) 2013-04-10 — — EP disclosed
Send feedback